Does ARGATROBAN Cause Hypofibrinogenaemia? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hypofibrinogenaemia have been filed in association with ARGATROBAN (Argatroban). This represents 1.6% of all adverse event reports for ARGATROBAN.
11
Reports of Hypofibrinogenaemia with ARGATROBAN
1.6%
of all ARGATROBAN reports
0
Deaths
8
Hospitalizations
How Dangerous Is Hypofibrinogenaemia From ARGATROBAN?
Of the 11 reports, 8 (72.7%) required hospitalization.
Is Hypofibrinogenaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARGATROBAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ARGATROBAN Cause?
Drug ineffective (109)
Heparin-induced thrombocytopenia (91)
Off label use (55)
Haemorrhage (45)
Cerebral infarction (35)
Disseminated intravascular coagulation (35)
Pulmonary embolism (30)
Deep vein thrombosis (29)
Thrombocytopenia (29)
Thrombosis (25)
What Other Drugs Cause Hypofibrinogenaemia?
METHOTREXATE (297)
PEGASPARGASE (296)
VINCRISTINE (295)
DAUNORUBICIN (186)
CYTARABINE (177)
DEXAMETHASONE (174)
HYDROCORTISONE (126)
PREDNISONE (124)
TOCILIZUMAB (121)
PREDNISOLONE (117)
Which ARGATROBAN Alternatives Have Lower Hypofibrinogenaemia Risk?
ARGATROBAN vs ARGININE
ARGATROBAN vs ARGININE\LYSINE
ARGATROBAN vs ARIMIDEX
ARGATROBAN vs ARIPIPRAZOLE
ARGATROBAN vs ARIPIPRAZOLE LAUROXIL